Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 14 studies | 29% ± 14% | |
astrocyte | 12 studies | 35% ± 17% | |
microglial cell | 10 studies | 30% ± 11% | |
oligodendrocyte | 10 studies | 34% ± 12% | |
glutamatergic neuron | 9 studies | 44% ± 25% | |
oligodendrocyte precursor cell | 9 studies | 31% ± 13% | |
macrophage | 8 studies | 32% ± 13% | |
adipocyte | 8 studies | 29% ± 9% | |
fibroblast | 8 studies | 25% ± 9% | |
GABAergic neuron | 7 studies | 45% ± 22% | |
interneuron | 6 studies | 42% ± 22% | |
neuron | 5 studies | 39% ± 20% | |
endothelial cell of lymphatic vessel | 5 studies | 28% ± 11% | |
smooth muscle cell | 5 studies | 21% ± 3% | |
cardiac muscle cell | 4 studies | 21% ± 1% | |
myeloid cell | 4 studies | 27% ± 7% | |
monocyte | 4 studies | 21% ± 5% | |
pericyte | 4 studies | 25% ± 8% | |
GABAergic interneuron | 3 studies | 29% ± 8% | |
granule cell | 3 studies | 31% ± 7% | |
dendritic cell | 3 studies | 24% ± 6% | |
hepatocyte | 3 studies | 41% ± 19% | |
epithelial cell | 3 studies | 30% ± 18% | |
B cell | 3 studies | 22% ± 5% | |
alveolar macrophage | 3 studies | 27% ± 7% | |
club cell | 3 studies | 25% ± 8% | |
natural killer cell | 3 studies | 19% ± 1% | |
type I pneumocyte | 3 studies | 26% ± 6% | |
type II pneumocyte | 3 studies | 24% ± 6% | |
lymphocyte | 3 studies | 34% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3220.94 | 1445 / 1445 | 100% | 19.78 | 183 / 183 |
prostate | 100% | 2730.68 | 245 / 245 | 100% | 13.34 | 501 / 502 |
uterus | 100% | 3108.17 | 170 / 170 | 100% | 13.24 | 457 / 459 |
skin | 100% | 3039.31 | 1808 / 1809 | 100% | 24.76 | 470 / 472 |
stomach | 100% | 1990.64 | 359 / 359 | 99% | 15.25 | 284 / 286 |
breast | 100% | 1914.81 | 459 / 459 | 99% | 15.20 | 1110 / 1118 |
brain | 100% | 2434.99 | 2630 / 2642 | 100% | 20.12 | 703 / 705 |
intestine | 100% | 3146.46 | 966 / 966 | 99% | 13.88 | 523 / 527 |
bladder | 100% | 3301.24 | 21 / 21 | 99% | 12.99 | 500 / 504 |
thymus | 100% | 1948.45 | 652 / 653 | 99% | 13.70 | 601 / 605 |
ovary | 100% | 2096.59 | 180 / 180 | 99% | 13.84 | 426 / 430 |
kidney | 100% | 1581.31 | 89 / 89 | 99% | 13.52 | 891 / 901 |
lung | 100% | 2141.17 | 577 / 578 | 99% | 14.54 | 1140 / 1155 |
adrenal gland | 100% | 2652.64 | 258 / 258 | 98% | 18.21 | 226 / 230 |
pancreas | 98% | 1078.89 | 321 / 328 | 99% | 10.72 | 176 / 178 |
liver | 100% | 1265.73 | 225 / 226 | 97% | 9.69 | 394 / 406 |
adipose | 100% | 1982.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2685.96 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 27.19 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.88 | 29 / 29 |
muscle | 100% | 4519.63 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2096.16 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.16 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.06 | 1 / 1 |
heart | 98% | 1825.05 | 842 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 70% | 1025.85 | 649 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0001558 | Biological process | regulation of cell growth |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_1901331 | Biological process | positive regulation of odontoblast differentiation |
GO_0031929 | Biological process | TOR signaling |
GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
GO_0006974 | Biological process | DNA damage response |
GO_0046889 | Biological process | positive regulation of lipid biosynthetic process |
GO_0009267 | Biological process | cellular response to starvation |
GO_1900087 | Biological process | positive regulation of G1/S transition of mitotic cell cycle |
GO_0045672 | Biological process | positive regulation of osteoclast differentiation |
GO_0031669 | Biological process | cellular response to nutrient levels |
GO_1905857 | Biological process | positive regulation of pentose-phosphate shunt |
GO_0010506 | Biological process | regulation of autophagy |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0045945 | Biological process | positive regulation of transcription by RNA polymerase III |
GO_0071470 | Biological process | cellular response to osmotic stress |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0008361 | Biological process | regulation of cell size |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0010800 | Biological process | positive regulation of peptidyl-threonine phosphorylation |
GO_0035176 | Biological process | social behavior |
GO_0045821 | Biological process | positive regulation of glycolytic process |
GO_0032008 | Biological process | positive regulation of TOR signaling |
GO_0038202 | Biological process | TORC1 signaling |
GO_0071233 | Biological process | cellular response to L-leucine |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0005764 | Cellular component | lysosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030425 | Cellular component | dendrite |
GO_0005829 | Cellular component | cytosol |
GO_0031931 | Cellular component | TORC1 complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0140767 | Molecular function | enzyme-substrate adaptor activity |
GO_0030291 | Molecular function | protein serine/threonine kinase inhibitor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0030295 | Molecular function | protein kinase activator activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | RPTOR |
Protein name | Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein) Regulatory associated protein of MTOR complex 1 |
Synonyms | RAPTOR KIAA1303 |
Description | FUNCTION: Component of the mechanistic target of rapamycin complex 1 (mTORC1), an evolutionarily conserved central nutrient sensor that stimulates anabolic reactions and macromolecule biosynthesis to promote cellular biomass generation and growth . In response to nutrients, growth factors or amino acids, mTORC1 is recruited to the lysosome membrane and promotes protein, lipid and nucleotide synthesis by phosphorylating several substrates, such as ribosomal protein S6 kinase (RPS6KB1 and RPS6KB2) and EIF4EBP1 (4E-BP1) . In the same time, it inhibits catabolic pathways by phosphorylating the autophagy initiation components ULK1 and ATG13, as well as transcription factor TFEB, a master regulators of lysosomal biogenesis and autophagy . The mTORC1 complex is inhibited in response to starvation and amino acid depletion . Within the mTORC1 complex, RPTOR acts both as a molecular adapter, which (1) mediates recruitment of mTORC1 to lysosomal membranes via interaction with small GTPases Rag (RagA/RRAGA, RagB/RRAGB, RagC/RRAGC and/or RagD/RRAGD), and a (2) substrate-specific adapter, which promotes substrate specificity by binding to TOS motif-containing proteins and direct them towards the active site of the MTOR kinase domain for phosphorylation . mTORC1 complex regulates many cellular processes, such as odontoblast and osteoclast differentiation or neuronal transmission (By similarity). mTORC1 complex in excitatory neuronal transmission is required for the prosocial behavior induced by the psychoactive substance lysergic acid diethylamide (LSD) (By similarity). . |
Accessions | ENST00000544334.6 [Q8N122-3] ENST00000570891.5 [Q8N122-2] ENST00000576366.1 ENST00000697423.1 I3L436 I3L2I3 A0A8V8TMD9 ENST00000574767.5 Q8N122 ENST00000306801.8 [Q8N122-1] |